{"data":{"id":"us/21-cfr-516.24","jurisdiction":"us","citation":"21 CFR 516.24","heading":"Granting MUMS-drug designation.","body":"(a) FDA may grant the request for MUMS-drug designation if none of the reasons described in § 516.25 for refusal to grant such a request apply.\n(b) When a request for MUMS-drug designation is granted, FDA will notify the sponsor in writing and will give public notice of the MUMS-drug designation in accordance with § 516.28.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES","Subpart B—Designation of a Minor Use or Minor Species New Animal Drug"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"8a420716826f263f010007c5588985dfd3e6885892779b6358db0319d0e562a3","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-516.23","next":"us/21-cfr-516.25"},"notice":"GroundRules: Original legal text. Not legal advice."}